Search the Newsreel

Sensient Technologies stock hits all-time high at 132.78 USD By Investing.com

Sensient Technologies (SXT) stock has reached an all-time high of $132.78, trading just below its 52-week high, with a significant surge of over 40% in the past six months and year-to-date. Despite InvestingPro's assessment of the company being overvalued, it has a strong dividend …

First Sensor AG legt Ergebniszahlen für die neun Monate bis zum 30. Juni 2026 vor

Sensus Healthcare, Inc. Q2 2026: Revenue $2.29M, EPS $(0.53) — 10-Q Summary

Sensus Healthcare, Inc. (SRTS) reported a significant decline in its Q2 2026 financial results, with revenue falling to $2.29M and diluted EPS at $(0.53). This downturn was primarily attributed to fewer system sales, a shift towards Fair Deal Agreements and rental arrangements impacting revenue …

T. Rowe Price Associates (ST) discloses 9.53M Sensata shares in Schedule 13G/A

T. Rowe Price Associates, Inc. filed an amended Schedule 13G/A, reporting a beneficial ownership of 9,526,046 shares of Sensata Technologies Holding common stock, which represents 6.6% of the class as of June 30, 2026. The filing indicates sole voting power over 9,492,531 shares and …

Sensata Technologies Holding N.V. $ST Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB significantly reduced its stake in Sensata Technologies Holding N.V. by 33.9% in the second quarter, selling over 124,000 shares but still retaining a substantial holding. Despite this sale, institutional ownership in Sensata remains high at 99.42%, and the company recently surpassed …

RoboSense Sets August 26 Board Meeting and Earnings Call for Interim Results

SenseTime Sets August Board Meeting to Approve Interim Results and Consider Dividend

Acusensus (ASX:ACE) Surges as Road Safety Technology Captures Strong Demand

SenSen Networks turns cash-flow positive as recurring revenue climbs to $11.7m

Sensus outlines shift to $250,000 average selling price as it targets a stronger second half

Earnings Call Insights: Sensus Healthcare (SRTS) Q2 2026 MANAGEMENT VIEW * "During the quarter, we secured equipment orders that we expected to be recognized in Q2. Third-party financing approval was not completed before June 30... which prevented us from recognizing 19 units and related …

Sensus Healthcare Q2 Adjusted Ebitda USD -3.0

This article reports that Sensus Healthcare's Q2 Adjusted EBITDA was USD -3.0. The content provided is extremely minimal, offering only this single financial data point.

Sensus Healthcare Q2 EPS $(0.53) misses estimate; sales fall 69%

Sensus Healthcare reported a significant decline in Q2 2026 revenue, falling 69% year-over-year to $2.3 million, missing analyst estimates. The company's net loss widened to $8.7 million, or $0.53 per share, primarily due to lower unit sales and delayed revenue recognition, along with a …

Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.41 EPS

Sensus Healthcare (NASDAQ:SRTS) announced its quarterly earnings, reporting a significant miss on both EPS and revenue expectations. The company posted a loss of $0.53 per share against an anticipated loss of $0.12, and revenue of $2.29 million, well below the $4.60 million estimate. Despite …

Earnings call transcript: Sensus Healthcare posts Q2 2026 miss, shares fall after hours

Sensus Healthcare reported a significant drop in Q2 revenue to $2.3 million from $7.3 million year-over-year, primarily due to delayed third-party financing for eight equipment units. The company expects to recognize this delayed revenue in Q3, leading to anticipated stronger second-half results. Sensus is …

Sensus Healthcare Inc (SRTS) Faces Challenges in Q2 Earnings: Re

Sensient Technologies (SXT) former major holders reduce beneficial stake to 0%

A group of former major shareholders, including Winder Pte. Ltd., Winder Investment Anstalt, Winder Anstalt, Haldor Foundation, and Freemont Capital Pte. Ltd., have filed an amended Schedule 13G/A, indicating they now beneficially own 0 shares of Sensient Technologies Corp. (SXT). This filing confirms that …

Sensata Technologies (ST): Artisan Partners group reports 0% ownership stake

Artisan Partners-related entities have filed a Schedule 13G/A indicating they no longer hold a reportable ownership stake in Sensata Technologies Holding plc (ST). As of June 30, 2026, the group, including Artisan Partners Asset Management Inc., Artisan Partners Holdings LP, Artisan Investments GP LLC, …

CMS Proposes 26% Increase in Sensus Hospital Delivery Code

Sensus Healthcare (SRTS) announced its Q2 2026 financial results, reporting a decrease in revenue to $2.3 million due to delayed financing approvals for eight units, which will now be recognized in Q3. Despite the revenue dip, the company noted strong commercial execution and a …

Inside Senseonics’ commercial overhaul and what’s next

Senseonics, a diabetes tech company, has taken over the commercialization and distribution of its Eversense 365 continuous glucose monitor (CGM) from Ascensia Diabetes Care, integrating sales and marketing teams in-house. This move aims to accelerate growth and allows for greater control over its business, …

Novosense Projects Strong Revenue Surge and Swing to Interim Profit in 2026

Liquidity Mapping Around (ST) Price Events

This article provides an AI-driven analysis for Sensata Technologies Holding Plc (NYSE: ST), identifying a weak near-term sentiment with potential long-term strength. It highlights a significant short setup with a 36.6:1 risk-reward ratio and details three distinct institutional trading strategies: Position Trading, Momentum Breakout, …

Senseonics Holdings, Inc. - Common Stock (Nasdaq:SENS) Stock Quote

This article provides a stock quote for Senseonics Holdings, Inc. (Nasdaq: SENS), detailing its current price, trading volume, and 52-week range. It also highlights recent news, including Q2 earnings exceeding expectations and a raised full-year revenue outlook, contributing to its positive year-to-date and monthly …

Consensus Cloud Solutions (CCSI) investor plans 5,400-share NASDAQ sale under Rule 144

Jeffrey Sullivan, a shareholder of Consensus Cloud Solutions (CCSI), plans to sell 5,400 shares of common stock on NASDAQ under Rule 144, valued at $203,583.78. The sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing also details Sullivan's …

Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?

DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a premium valuation. Growth catalysts remain visible across U.S. coverage, …

DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?

DexCom DXCM stock has rebounded sharply in 2026, gaining 34.8% after falling 14.7% in 2025, as investors increasingly recognize the company's improving growth profile and expanding continuous glucose monitoring (CGM) opportunity. The company's share price performance so far this year has outperformed the industry's …

Sensient Technologies (NYSE:SXT) Hits New 12-Month High - What's Next?

Sensient Technologies (NYSE:SXT) recently hit a new 52-week high of $132.47, driven by favorable analyst ratings and strong quarterly earnings. The company exceeded expectations with $1.20 EPS and $462.08 million in revenue, leading analysts like UBS and Robert W. Baird to raise their price …

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given Average Rating of "Moderate Buy" by Analysts

Senseonics Holdings, Inc. (NASDAQ:SENS) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $17.20, despite some recent target reductions. The company continues to face profitability challenges, reporting a wider-than-expected quarterly loss and projected full-year losses. Institutional investors …

Senstar Technologies to Report Second Quarter of 2026 Results on Tuesday August 25, 2026

Senstar Technologies Corporation announced it will release its second-quarter 2026 financial results on Tuesday, August 25, 2026. Management will host a conference call at 9:00 a.m. Eastern Time on the same day to discuss the results. The call details, including dial-in numbers and a …

Senstar Technologies to report Q2 2026 earnings on August 25 with a live conference call.

Senstar Technologies Corporation is scheduled to announce its financial results for the second quarter ending June 30, 2026, on August 25, 2026. The company will host a conference call at 9:00 a.m. Eastern Time to discuss these results, with both phone and live webcast …

Senstar Technologies' Q2 Results Call Set for Aug. 25 at 9 a.m. ET

Senstar Technologies (NASDAQ: SNT) will release its second-quarter financial results on Tuesday, August 25, 2026, for the period ending June 30, 2026. Management will host an earnings conference call at 9:00 a.m. Eastern Time on the same day to discuss the results. Investors can …

HC Wainwright Issues Pessimistic Estimate for SENS Earnings

Consensus Cloud Solutions, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Consensus Cloud Solutions (NASDAQ: CCSI) recently reported Q2 results, with revenues matching expectations and EPS exceeding predictions by 14%. Following these results, analysts have become more optimistic about the company's earnings potential, raising their price targets by 6.4% to US$41.75. Despite this, revenue growth …

Sensient Technologies Corporati (SXT) Stock Forecasts

Argus has raised its target price for Sensient Technologies Corp (SXT) to $134.00, citing the company's role as a manufacturer and marketer of natural and synthetic colors, flavors, and other specialty ingredients. The current price of SXT stock is $130.33. This report provides a …